ProText Mobility, Inc. (TXTM)

Market Cap	20.22M
Revenue	n/a
Net Income	n/a
Shares Out	8.79B
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,410,590
Average Volume	17,879,617
Open	0.0022
Previous Close	0.0022
Day's Range	0.0021 - 0.0025
52-Week Range	0.0001 - 0.0056
Beta	-2.24
RSI	38.55
Earnings Date	n/a

About ProText Mobility

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida. ProText Mobility, Inc. operates as a subsidiary of Plandaí Biotechnology, Inc.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Roger Baylis-Duffield
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: TXTM